✨ Free AI Report
Tango Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Tango Therapeutics, Inc.
Research Preview

Tango Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

Tango Therapeutics is a clinical-stage precision oncology company focused on discovering novel drug targets for cancer treatment using synthetic lethality principles. The company develops genetically targeted therapie...

Analyst-debate audio for Tango Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for Tango Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Tango Therapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Precision oncology player targeting underserved populations with synthetic lethality approach, but dependent on clinical...

Read the full analyst-debate transcript →
Industry Biotechnology - Precision Oncology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Tango Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Tango Therapeutics, Inc. Overview

Pro stress-test →

Tango Therapeutics is a clinical-stage precision oncology company focused on discovering novel drug targets for cancer treatment using synthetic lethality principles. The company develops genetically targeted therapies aimed at specific patient populations with unmet medical needs.

Strategic Profile

Pro stress-test →

Tango leverages synthetic lethality and novel genetics-based approaches to develop medicines that take direct aim at specific tumors, including expanding into tumor suppressor gene loss and immune evasion mechanisms. The company's pipeline includes PRMT5 inhibitors for both CNS and non-CNS cancers, plus CoREST platform programs.

Competitive Landscape

Pro stress-test →

Tango competes in the precision oncology space with companies including Prelude Therapeutics, Repare Therapeutics, IDEAYA Biosciences, and FoRx Therapeutics. The competitive advantage lies in the synthetic lethality platform and patient-centric approach to genetically defined tumors.

Industry Context

Tango Therapeutics, Inc. operates in Biotechnology - Precision Oncology.

Key facts

Founded: 2017 · Headquarters: Boston, Massachusetts · Revenue: $66.5M · Market cap: $1.41B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Tango Therapeutics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Tango Therapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Precision Oncology PlatformDNA damage response inhibitorsHomologous Recombination RepairRAD51 inhibitors for precision oncologyPrecision Cancer MedicineTargeted therapies for defined patient populations

Compare Tango Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Tango Therapeutics, Inc. operates in Biotechnology - Precision Oncology. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Precision Oncology research →
NEW · MCP server

Ask your AI assistant about Tango Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Tango Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did Tango Therapeutics, Inc. do this quarter?”
“Is Tango Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Tango Therapeutics, Inc. do?+
Tango Therapeutics is a clinical-stage precision oncology company focused on discovering novel drug targets for cancer treatment using synthetic lethality principles. The company develops genetically targeted therapie...
What is Tango Therapeutics, Inc.'s Cyborg Score?+
Tango Therapeutics, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Tango Therapeutics, Inc.'s main competitors?+
Named competitors include Precision Oncology Platform, Homologous Recombination Repair, Precision Cancer Medicine. The full competitive landscape is in the AskCyborg report.
How can I get the full Tango Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Tango Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Tango Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual